Lucia Sparavigna

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)

Caterina Caminiti, Jane Bryce, Silvia Riva, Diane Ng et autres

INTRODUCTION: ) is a library of 78 symptom terms and 124 items enabling patient reporting of symptomatic adverse events in cancer trials. This multicenter study used mixed methods to develop an Italian language version of this widely accepted measure, and describe the …

it, us (code pays fourni par la source)

Content Validity and Reliability of the Italian Language Version of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®)

Caterina Caminiti, Jane Bryce, Silvia Riva, Diane Ng et autres

ABSTRACT Introduction: The US National Cancer Institute’s (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) is a library of 78 symptom terms and 124 items enabling patient reporting of symptomatic adverse events in cancer trials. This multicenter …

Content Validity and Reliability of the Italian Language Version of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®)

Caterina Caminiti, Jane Bryce, Silvia Riva, Diane Ng et autres

ABSTRACT Introduction: The US National Cancer Institute’s (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) is a library of 78 symptom terms and 124 items enabling patient reporting of symptomatic adverse events in cancer trials. This multicenter …

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Francesco Perrone, Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et autres

BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients.MethodsA multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of tocilizumab on lethality rates …

it, us (code pays fourni par la source)

A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system

Silvia Riva, Fabio Efficace, Massimo Di Maïo, Jane Bryce et autres

gb, it, us (code pays fourni par la source)

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani, Roberto Parrella et autres

BACKGROUND: Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients. METHODS: A multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of tocilizumab …

it (code pays fourni par la source)

Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT).

Jane Bryce, Silvia Riva, Massimo Di Maïo, Fabio Efficace et autres

91 Background: Financial toxicity in cancer patients has been initially reported in the United States and subsequently in other countries, including Italy, despite its health care system is grounded on universal coverage. Considering that the way healthcare and welfare systems are shaped …

it, gb, be (code pays fourni par la source)

Un’applicazione delle reti bayesiane nell’individuazione delle cause di incidente

Lucia Sparavigna

La tesi di dottorato, Un’applicazione delle Reti Bayesiane nell’individuazione delle cause di incidente, propone una metodologia per valutare le condizioni che compromettono la sicurezza nella circolazione stradale (aumento della probabilità del verificarsi di un incidente) e che quindi sia di supporto per …